GB201612920D0 - Composition for the treatment of Duchenne Muscular Dystrophy - Google Patents
Composition for the treatment of Duchenne Muscular DystrophyInfo
- Publication number
- GB201612920D0 GB201612920D0 GBGB1612920.7A GB201612920A GB201612920D0 GB 201612920 D0 GB201612920 D0 GB 201612920D0 GB 201612920 A GB201612920 A GB 201612920A GB 201612920 D0 GB201612920 D0 GB 201612920D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- treatment
- composition
- muscular dystrophy
- duchenne muscular
- duchenne
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Priority Applications (12)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1612920.7A GB201612920D0 (en) | 2016-07-26 | 2016-07-26 | Composition for the treatment of Duchenne Muscular Dystrophy |
MX2018012018A MX2018012018A (en) | 2016-03-30 | 2017-03-29 | Composition for the treatment of duchenne muscular dystrophy. |
BR112018070076-2A BR112018070076A2 (en) | 2016-03-30 | 2017-03-29 | composition for the treatment of duchenne muscular dystrophy |
AU2017243198A AU2017243198A1 (en) | 2016-03-30 | 2017-03-29 | Composition for the treatment of duchenne muscular dystrophy |
EP17720203.3A EP3500245A1 (en) | 2016-03-30 | 2017-03-29 | Composition for the treatment of duchenne muscular dystrophy |
JP2018551258A JP2019510056A (en) | 2016-03-30 | 2017-03-29 | Composition for the treatment of Duchenne muscular dystrophy |
CN201780033487.5A CN109803641A (en) | 2016-03-30 | 2017-03-29 | For treating the composition of Du's Xing Shi muscular dystrophy |
PCT/GB2017/050884 WO2017168151A1 (en) | 2016-03-30 | 2017-03-29 | Composition for the treatment of duchenne muscular dystrophy |
KR1020187031329A KR20190026647A (en) | 2016-03-30 | 2017-03-29 | Composition for the treatment of duchlene muscular dystrophy |
US16/144,809 US20200016076A1 (en) | 2016-03-30 | 2018-09-27 | Composition for the treatment of duchenne muscular dystrophy |
IL262013A IL262013A (en) | 2016-03-30 | 2018-09-27 | Composition for the treatment of duchenne muscular dystrophy |
PH12018502276A PH12018502276A1 (en) | 2016-03-30 | 2018-10-25 | Composition for the treatment of duchenne muscular dystrophy |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1612920.7A GB201612920D0 (en) | 2016-07-26 | 2016-07-26 | Composition for the treatment of Duchenne Muscular Dystrophy |
Publications (1)
Publication Number | Publication Date |
---|---|
GB201612920D0 true GB201612920D0 (en) | 2016-09-07 |
Family
ID=56894525
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB1612920.7A Ceased GB201612920D0 (en) | 2016-03-30 | 2016-07-26 | Composition for the treatment of Duchenne Muscular Dystrophy |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB201612920D0 (en) |
-
2016
- 2016-07-26 GB GBGB1612920.7A patent/GB201612920D0/en not_active Ceased
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL290160A (en) | Compositions and methods for treating duchenne muscular dystrophy and related disorders | |
HK1244838A1 (en) | Crispr/cas-related methods and compositions for treating duchenne muscular dystrophy and becker muscular dystrophy | |
PL3663296T3 (en) | Process for the preparation of compounds useful for treating spinal muscular atrophy | |
IL275482A (en) | Esketamine for the treatment of depression | |
HK1257247A1 (en) | Methods and compositions for the prevention and treatment of duchenne muscular dystrophy | |
SI3524255T1 (en) | Composition for the treatment of acne | |
ZA201704957B (en) | Composition for the treatment of hepatic veno-occlusive disease | |
EP3328374A4 (en) | Glutamine antagonists for the treatment of cognitive deficits | |
PT3286317T (en) | Dynamin 2 inhibitor for the treatment of duchenne's muscular dystrophy | |
ZA201601869B (en) | Improved process for the preparation of apremilast | |
EP3307891B8 (en) | Combined therapy for duchenne muscular dystrophy | |
IL259178A (en) | Methods of treating muscular dystrophy | |
IL253773B (en) | Treatment of facioscapulohumeral dystrophy | |
HK1246146A1 (en) | Pharmaceutical composition for the treatment of mycosis | |
IL262013A (en) | Composition for the treatment of duchenne muscular dystrophy | |
IL255167A0 (en) | Compositions for the treatment of cancer | |
GB201612920D0 (en) | Composition for the treatment of Duchenne Muscular Dystrophy | |
GB201605383D0 (en) | Composition for the treatment of duchenne muscular dystrophy | |
GB201605380D0 (en) | Composition for the treatment of duchenne muscular dystrophy | |
PT3310711T (en) | Process for the preparation of sodiuim cyanide | |
PL3164110T3 (en) | Pharmaceutical compositions for the treatment of psoriasis | |
IL267059A (en) | Composition for the treatment of osteoarthritis | |
GB201418513D0 (en) | Compounds for the treatment of muscular dystrophy having improved bioavailability | |
PT3524255T (en) | Composition for the treatment of acne |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |